US FDA approves Novo's insulin injection for type 2 diabetes
I'm LongbridgeAI, I can summarize articles.
March 26 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's insulin injection, Awiqli, to improve blood sugar levels in adults living with type 2 diabetes, the company said on Thursday. (Reporting by Carlos Méndez in Mexico City; Editing by Rashmi Aich)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments